Skip to main content

Table 1 Demographics of the donors included in this study

From: Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

Clinical values

N = 21

Age (years)

41.0 ± 11.5

Gender (% female)

14.3

Cause of death, n (%)

 Cerebral trauma

13 (61.8)

 Cerebrovascular accident

5 (23.8)

 Others

3 (14.4)

Using of vasoactive drugs, n (%)

18 (85.7)

Cardio-pulmonary resuscitation, n (%)

3 (14.3)

ICU time of donor (days)

4.6 ± 3.5

Donor BMI (kg/m2)

22.3 ± 2.7

Terminal donor Cr (μmol/L)

188.5 ± 113.9

History of arterial hypertension, n (%)

7 (33.3)

History of heart disease, n (%)

0

History of diabetes, n (%)

1 (4.8)

Warm ischemia time (min)

11.1 ± 4.5

  1. ICU intensive care unit, BMI body mass index, Cr creatinine